Both AADR and BIS are ETFs. AADR has a higher 5-year return than BIS (5.23% vs -25%). AADR has a higher expense ratio than BIS (1.1% vs 0.95%). Below is the comparison between AADR and BIS.
| AADR | BIS | |
|---|---|---|
| Security Type | ETF | ETF |
| Segment | Equity: Global Ex-U.S. - Total Market Growth | Inverse Equity: U.S. Biotech |
| Family | AdvisorShares | ProShares |
| Net Assets | $43.70M | $9.70M |
| Expense Ratio | 1.10% | 0.95% |
| Management Style | passive (index-based) | passive (index-based) |
| Dividend Yield | 0.31% | 0.00% |
| Underlying Index | -- | NASDAQ Biotechnology Index |
| YTD Return | -17.18% | 7.87% |
| 1-Year Return | -22.50% | 35.52% |
| 3-Year Return | 2.08% | -32.94% |
| 5-Year Return | 5.23% | -25.00% |
| 10-Year Return | 6.83% | -34.35% |
AADR
AADR description
The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.
AADR performance & returns
| YTD Return | -17.18% |
| 1-Month Return | 9.02% |
| 3-Month Return | 2.72% |
| 1-Year Return | -22.50% |
| 3-Year Return | 2.08% |
| 5-Year Return | 5.23% |
| 10-Year Return | 6.83% |
AADR holdings
Top 10 Holdings (38.80% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| ASML Holding NV ADR | ASML | 5.52% |
| BioNTech SE ADR | BNTX.DE | 4.57% |
| Danaos Corp | DAC.AX | 4.48% |
| LVMH Moet Hennessy Louis Vuitton SE ADR | LVMUY.PA | 4.16% |
| Himax Technologies Inc ADR | HIMX | 3.79% |
| Sibanye Stillwater Ltd ADR | SBSW.JO | 3.64% |
| Logitech International SA | LOGN | 3.51% |
| Cemex SAB de CV ADR | CX.MX | 3.22% |
| Embraer SA ADR | ERJ.SA | 3.06% |
| POSCO ADR | PKX.KS | 2.85% |
AADR pros
None that we could think of.AADR cons
None that we could think of.Other relevant AADR comparisons
You may also want to check out the following AADR comparisons that investors often look for on Finny
BIS
BIS description
The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
BIS performance & returns
| YTD Return | 7.87% |
| 1-Month Return | -6.27% |
| 3-Month Return | -37.01% |
| 1-Year Return | 35.52% |
| 3-Year Return | -32.94% |
| 5-Year Return | -25.00% |
| 10-Year Return | -34.35% |
BIS holdings
Top 10 Holdings (199.98% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Nasdaq Biotechnology Index Swap Societe Generale | N/A | 62.16% |
| Nasdaq Biotechnology Index Swap Ubs Ag | N/A | 61.92% |
| Nasdaq Biotechnology Index Swap Bank Of America Na | N/A | 57.92% |
| Nasdaq Biotechnology Index Swap Citibank Na | N/A | 14.79% |
| Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc | N/A | 3.19% |
BIS pros
None that we could think of.BIS cons
None that we could think of.Other relevant BIS comparisons
You may also want to check out the following BIS comparisons that investors often look for on Finny